The efficacy and safety of the dipeptidyl peptidase-4 inhibitor saxagliptin in treatment-naive patients with type 2 diabetes mellitus: a randomized controlled trial
… in the United States, Russia, India, and Taiwan. Inclusion and … for diabetes for a total of <6 months since original diagnosis. … The overall incidences of marked laboratory abnormalities …..... Read More